Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Best Time Take Melanotan-2 Morning Night: Peptide Comparison

Melanotan-2 7–9 PM (evening) MC4R peaks 8 PM–12 AM; MC1R peaks 9 PM–2 AM 60–90 min to peak plasma; enhanced in fasted state Nausea, flushing 30–90 min post-injection; resolves in 2–4 hours Evening dosing captures circadian receptor peaks and isolates side effe

This comparison does not assign a generated winner or score.

  • Melanotan-2
  • 7–9 PM (evening)
  • MC4R peaks 8 PM–12 AM; MC1R peaks 9 PM–2 AM
  • 60–90 min to peak plasma; enhanced in fasted state
  • Nausea, flushing 30–90 min post-injection; resolves in 2–4 hours
  • Evening dosing captures circadian receptor peaks and isolates side effects to sleep hours. Objectively superior to morning protocols
  • PT-141 (Bremelanotide)
  • 60–90 min pre-activity
  • MC3R/MC4R activation independent of circadian timing
  • 30–60 min to peak plasma; faster than MT2
  • Flushing, nausea similar timing but shorter duration
  • Timing driven by desired effect window, not receptor cycles. Fundamentally different from MT2
  • Ipamorelin
  • Before bed (9–11 PM)
  • Growth hormone pulse peaks during deep sleep (Stage 3)
  • 15–30 min to peak plasma; very fast absorption
  • Minimal. Transient hunger in some users
  • GH-releasing peptides exploit sleep-phase GH secretion; mistimed dosing wastes the peptide
  • BPC-157
  • Twice daily (morning + evening)
  • No circadian receptor variation
  • Steady-state plasma levels with BID dosing
  • Essentially none at research doses
  • Healing peptides work via cumulative tissue exposure, not receptor timing
More references

Related material